(Q41484969)

1 October 2017

1 reference

title

Diagnosis and management of glomerular diseases (English)

1 reference

1 October 2017

Jennette JC

1

1 reference

PubMed ID

9167650

1 October 2017

Falk RJ

series ordinal

2

1 reference

1 October 2017

1 May 1997

1 reference

Medical Clinics of North America

1 October 2017

1 reference

1 October 2017

81

1 reference

1 October 2017

3

1 reference

1 October 2017

653-677

1 reference

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

NIH conference. Lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Poststreptococcal glomerulonephritis in children: clinicopathological correlations and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Therapy in IgA nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Glomerular basement membrane abnormalities associated with apparently idiopathic hematuria: ultrastructural morphometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The many masks of focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Plasma levels of atrial natriuretic peptide in transient left ventricular ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Diabetic nephropathy: strategies in prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The immunohistology of IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Adult minimal change glomerulopathy with acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The pathology of vasculitis involving the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Minimal-change glomerulopathy of adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

IgA nephropathy: common nephritis leading to end-stage renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Idiopathic membranous nephropathy--to treat or not to treat?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Incipient nephropathy in type 1 (insulin-dependent) diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Predicting diabetic nephropathy in insulin-dependent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Dense intramembranous deposit disease: new pathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

7 January 2021

Treatment of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Thin-basement-membrane nephropathy in adults with persistent hematuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Therapy of focal segmental glomerulosclerosis with cyclosporine A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

Diagnosis and management of glomerulonephritis and vasculitis presenting as acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970538-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70538-1

1 reference

1 October 2017

1 reference

PubMed ID

9167650